-----Original Message-----
To: info@cistronbio.com <info@cistronbio.com>
Date: Monday, October 25, 1999 10:30 PM
Subject: $18 Million Note Due 4/15/11 @ 6.35%
>Cistron Biotechnology is referenced in the 7/8/99 N-30D SEC filing by Strong
>Income Fund, Inc. :
>
>STRONG SHORT-TERM BOND FUND
>
>Cistron Biotechnology, Inc.
>Asset-Backed Notes
>Series 1997-A
>Class A-6
>6.35%
>Due 4/15/11
>Shares or Principal Amount: 17,955,000
>Value: $18,181,143
>
>Today, I contacted a representative of Strong Income Fund, Inc., at
>1-800-368-1030, to verify the accuracy of their N-30D filing. I was assured
>that the reference to Cistron Biotechnology was correct. I was told that it
>is possible that the note was paid off early. However, the note was issued
>to Cistron Biotechnology in 1997. Why did Cistron enter into that
>agreement? Why isn't that debt on the balance sheet of Cistron's latest SEC
>filing? Why was there no reference to that debt in any of the 1997 SEC
>filings by Cistron Biotechnology? If Cistron paid off that debt early, from
>where did Cistron get that money?
>
>As a shareholder, I would appreciated your prompt detailed response to the
>four questions above. I believe I should allow Cistron a chance to respond
>before I contact any other firms or agencies.
>
>Thank you,
>
>Walter Morton
>Independent Investor
I also faxed a letter to Hal Smith with my fax number and email address included.
I have not received a response from CIST or Hal Smith. |
